SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-054577
Filing Date
2013-07-16
Accepted
2013-07-15 18:30:31
Documents
8
Period of Report
2013-07-15
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-16627_18k.htm 8-K 107858
2 EX-3.1 a13-16627_1ex3d1.htm EX-3.1 9937
3 EX-3.2 a13-16627_1ex3d2.htm EX-3.2 9524
4 EX-4.1 a13-16627_1ex4d1.htm EX-4.1 5000
5 EX-99.1 a13-16627_1ex99d1.htm EX-99.1 17017
6 GRAPHIC g166271mmi001.gif GRAPHIC 4816
7 GRAPHIC g166271kii001.gif GRAPHIC 265395
8 GRAPHIC g166271kii002.gif GRAPHIC 36335
  Complete submission text file 0001104659-13-054577.txt   573885
Mailing Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130
Business Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130 858-436-3900
Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35119 | Film No.: 13969101
SIC: 2834 Pharmaceutical Preparations